Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
2′-deoxyuridine
14%
5-bisphosphate
14%
5-fluorouracil (5-FU)
28%
5′-monophosphate
28%
Anticancer Agents
100%
Antifolate
14%
Antineoplastic Agents
14%
Bench to Bedside
100%
Cancer Cells
14%
Cancer Chemotherapy
14%
Cellular Drugs
28%
Clinical Efficacy
14%
Deoxythymidine
28%
Drug Resistance
28%
First-in-class
14%
Folate
14%
Folate Enzymes
14%
Future Success
14%
Human Malignancies
14%
In Cancer
14%
Inhibitor Compound
42%
Nolatrexed
14%
Novel Combination Therapy
14%
Novel Mechanism
28%
Nucleoside Analogues
14%
Pemetrexed
14%
Potent Inhibitor
14%
Raltitrexed
14%
Reductive Methylation
14%
Resistance Mechanism
14%
Thymidylate Synthase
100%
Thymidylate Synthase Inhibitors
100%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
100%
Cancer Chemotherapy
14%
Combination Therapy
14%
Deoxyuridine
14%
Drug Resistance
28%
Enzymes
14%
Fluorouracil
28%
Folic Acid
28%
Folic Acid Antagonist
14%
Malignant Neoplasm
14%
Nolatrexed
14%
Pemetrexed
14%
Plevitrexed
14%
Raltitrexed
14%
Thymidine
28%
Thymidylate Synthase
100%
Thymidylate Synthase Inhibitor
100%